
    
      BCG maintenance immunotherapy 1/3 dose : 27 mg two randomized arms : 3 or 6 months for 36
      months clinical side effects according to OMS score efficacy regarding recurrence : cytology
      and cystoscopy PSA, leucocyturia and N-ramp gene evaluation
    
  